Placemark Investments’s iShares Biotechnology ETF IBB Stock Holding History

Placemark Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$957K	Buy	9,465 +3,702	+64%	+$360K	0.02%	900
2014 Q3	$525K	Sell	5,763 -8,388	-59%	-$736K	0.01%	1152
2014 Q2	$1.21M	Sell	14,151 -1,980	-12%	-$156K	0.02%	784
2014 Q1	$1.27M	Buy	16,131 +939	+6%	+$78.2K	0.02%	705
2013 Q4	$1.15M	Buy	15,192 +2,088	+16%	+$148K	0.02%	800
2013 Q3	$915K	Buy	13,104 +7,218	+123%	+$473K	0.02%	851
2013 Q2	$341K	Buy	+5,886	New	+$340K	0.01%	1210

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Placemark Investments's IBB Position: Q4 2014 in Review

Placemark Investments increased its iShares Biotechnology ETF (IBB) stake by 64% in Q4 2014, buying an estimated $360K and bringing the position to 9,465 shares worth $957K. The position accounts for 0.02% of the portfolio, ranked #900.

Placemark Investments first reported a position in IBB in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.27M in Q1 2014. 370 funds tracked by Wall St. Rank hold IBB as of Q4 2014.

Placemark Investments held 9,465 shares of iShares Biotechnology ETF worth $957K as of Q4 2014.
Placemark Investments bought 3,702 iShares Biotechnology ETF shares in Q4 2014, an estimated $360K.
iShares Biotechnology ETF made up 0.02% of Placemark Investments's portfolio in Q4 2014, its #900 holding.
Placemark Investments first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's iShares Biotechnology ETF position peaked at $1.27M in Q1 2014.
370 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.